Indian Official Sees Agreement With Japan On Trade In Indian Generics
This article was originally published in PharmAsia News
Executive Summary
An Indian trade negotiator says he sees signs Japan is relaxing its resistance to generic drugs from India, the source of some past friction. An Indian government official who has participated in four years of talks with Japanese counterparts said he expects an agreement soon between the two countries. He said he noticed the first signs of a positive response by Japanese officials who had been resisting inclusion of India's generic drugs in a bilateral trade agreement. (Click here for more
You may also be interested in...
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.